Natera (NTRA) Preferred Stock Liabilities (2014 - 2015)
Natera's (NTRA) quarterly Preferred Stock Liabilities came in at $240.6 million in Q2 2015, little changed quarter-over-quarter from $240.6 million in Q4 2014.
Powered by 
Analysis
Natera (NTRA) Preferred Stock Liabilities (2014 - 2015) Analysis & Trends
Natera (NTRA) has reported Preferred Stock Liabilities for 2 consecutive years, with $240.6 million the latest figure, recorded in Q2 2015.
- For the quarter ending Q2 2015, Preferred Stock Liabilities changed N/A year-over-year to $240.6 million; the trailing twelve-month figure through Jun 2015 stood at $240.6 million (changed N/A YoY), and the FY2014 full-year result was $240.6 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $240.6 million in Q2 2015 per NTRA's latest filing, from $240.6 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $240.6 million in Q4 2014 and bottomed at $240.6 million in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | - |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |